Page 5 - Rafaelg Amado News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zai Lab Announces That Repotrectinib Granted Priority Review by China s NMPA

SHANGHAI, China and CAMBRIDGE, Mass., May 18, 2023 Zai Lab Limited today announced that the Center for Drug Evaluation of China’s National Medical Products Administration has granted. | May 18, 2023

United statesHong kongUnited kingdomChristine chiou lina zhangJennifer chang xiaoyu chenRafaelg amadoDrug administrationZai lab limitedChina national medical products administrationPoint therapeutics incDrug registration regulation bureau orderZai labBristol myers squibbHead of global oncology researchExchange commissionZai lab forward

Zai Lab Announces Strategic Partnership and Global License Agreement with MediLink Therapeutics for a Next Generation Antibody-Drug Conjugate Program in Oncology

Zai Lab Announces Strategic Partnership and Global License Agreement with MediLink Therapeutics for a Next Generation Antibody-Drug Conjugate Program in Oncology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesRafaelg amadoLiang xiaoOrgilmma regzedmmaJennifer chang xiaoyu chenAlina zhangZai labHead of global oncology researchZai lab forwardAmerican association of cancer researchZai lab limitedChina national medical products administrationZai lab lung cancer franchiseExchange commissionDrug administration

Zai Lab Limited (ZLAB) Enters Partnership and License Agreement with MediLink Therapeutics for Antibody-Drug Conjugate Program in Oncology

Zai Lab Limited (ZLAB) Enters Partnership and License Agreement with MediLink Therapeutics for Antibody-Drug Conjugate Program in Oncology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesOrgilmma regzedmmaJennifer chang xiaoyu chenAlina zhangLiang xiaoRafaelg amadoAmerican association of cancer researchZai lab forwardDrug administrationZai labZai lab lung cancer franchiseChina national medical products administrationZai lab limitedHead of global oncology researchExchange commissionWall street

Poseida Therapeutics (PSTX) Appoints Rafael G Amado to its Board

Poseida Therapeutics (PSTX) Appoints Rafael G Amado to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesRafaelg amadoMark gergenHead of global oncology researchHead of researchUniversity of californiaPoseida therapeutics incDepartment of medicinePrior to zai labZai labGlobal development in therapeutic oncologyDivision of hematology oncologyAllogene therapeutics incAmgen incGlobal head of oncology research

Poseida Therapeutics Appoints Rafael G Amado, M D , to Board of Directors

/PRNewswire/ Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with.

Los angelesUnited statesRafaelg amadoMark gergenAmgen incZai labPrnewswire poseida therapeutics incPrior to zai labClinical researchDepartment of medicineHead of global oncology researchUniversity of californiaDivision of hematology oncologyGlobal development in therapeutic oncologyAllogene therapeutics incHead of research